Octreotide Acetate
NDC 0641-6177, Octreotide Acetate, injection, solution, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0641-6177
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076330
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTREOTIDE ACETATE200 ug/mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0641-6177-01 | 00641617701 | 1 VIAL, MULTI-DOSE in 1 CARTON (0641-6177-01) / 5 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9502860d-0261-4d69-a4be-827a5376d356Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0641-6177NADAC price for package 00641617701
GET /v1/drugs/nadac/00641617701
Use it
Look up 0641-6177 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0641-6177. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.